The Journal of Immunology · 2001 · 381 citations · 45 references
Life SciencesImmunologyOncologyCancer ImmunologyCellular ImmunologyImmunoregulationAntitumor T Cell ResponsesImmune Cell PhysiologyImmune ResponseNatural Killer Cell BiologyNatural Killer Cell RegulationT Cell BiologyAdaptive Antitumor ImmunityAntitumor Cytokine ResponsesAntitumor Interferon ResponsesMhc Class I MoleculesT-cell Immune ResponsesT-cell Responses To Tumor AntigensTh1 PolarizationTh2 Immune Response
Invariant NK T cells express certain NK cell receptors and an invariant TCRalpha chain specific for the MHC class I-like CD1d protein. These invariant NK T cells can regulate diverse immune responses in mice, including antitumor responses, through mechanisms including rapid production of IL-4 and IFN-gamma, but their physiological functions remain uncertain. Invariant NK T cells were markedly decreased in peripheral blood from advanced prostate cancer patients, and their ex vivo expansion with a CD1d-presented lipid Ag (alpha-galactosylceramide) was diminished compared with healthy donors. Invariant NK T cells from healthy donors produced high levels of both IFN-gamma and IL-4. In contrast, whereas invariant NK T cells from prostate cancer patients also produced IL-4, they had diminished IFN-gamma production and a striking decrease in their IFN-gamma:IL-4 ratio. The IFN-gamma deficit was specific to the invariant NK T cells, as bulk T cells from prostate cancer patients produced normal levels of IFN-gamma and IL-4. These findings support an immunoregulatory function for invariant NK T cells in humans mediated by differential production of Th1 vs Th2 cytokines. They further indicate that antitumor responses may be suppressed by the marked Th2 bias of invariant NK T cells in advanced cancer patients.
45
CD1d-Restricted and TCR-Mediated Activation of V <sub>α</sub> 14 NKT Cells by Glycosylceramides
Tetsu Kawano, Junqing Cui, Yasuhiko Koezuka et al. · Science · 1997 · 2.4K citations
Requirement for V <sub>α</sub> 14 NKT Cells in IL-12-Mediated Rejection of Tumors
Junqing Cui, Tahiro Shin, Tetsu Kawano et al. · Science · 1997 · 1.2K citations
CD1 Recognition by Mouse NK1 <sup>+</sup> T Lymphocytes
Albert Bendelac, Olivier Lantz, Mary E. Quimby et al. · Science · 1995 · 902 citations
Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
Mark J. Smyth, Kevin Thia, Shayna E.A. Street et al. · The Journal of Experimental Medicine · 2000 · 803 citations · Full text
Life Sciences, Immunology, Oncology +15